Ibex Investors LLC Sarepta Therapeutics, Inc. Put Options Transaction History
Ibex Investors LLC
- $59.6 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
534Shares Held
85.3MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$727 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$640 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$612 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$305 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$287 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $6.17B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...